Compare iShares Core MSCI EAFE ETF (IEFA) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core MSCI EAFE ETF vs Nomura Holdings Inc — how do they compare? iShares Core MSCI EAFE ETF trades at $96.56 (market cap $189.19B), while Nomura Holdings Inc trades at $9.61 (market cap $27.55B). The key difference: iShares Core MSCI EAFE ETF is far larger — about 6.9× Nomura Holdings Inc's market cap, and Nomura Holdings Inc pays a 3.4% dividend while iShares Core MSCI EAFE ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI EAFE ETF for 40 Days and Nomura Holdings Inc for 55 Days on average.
| IEFA | NMR | |
|---|---|---|
Market Cap | $189.19B | $27.55B |
Volume | 8,441,787 | 782,470 |
Sector | Broad Market / Factor | Financials |
52-Week High | $101.41 | $10.86 |
52-Week Low | $85.06 | $6.73 |
Typical Hold Time | 40 Days | 55 Days |
Enterprise Value | — | $38.54T |
Dividend Yield | — | 3.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEFA, the iShares Core MSCI EAFE ETF, trades at $96.52, up 0.33% on the day, but technical indicators signal a bearish trend with moving averages and oscillators in sell territory. The ETF provides exposure to developed markets outside North America, holding $196 billion in assets under management and offering a competitive expense ratio of 0.07%. Recent financial news highlights its role in international diversification, comparing favorably to peers on dividend yield and cost efficiency.
The outlook for IEFA is tempered by near-term technical weakness and broader market shifts away from concentrated U.S. tech exposure. Key risks include geopolitical tensions and interest rate uncertainty, but its low-cost structure and focus on established economies provide a defensive tilt for long-term investors seeking international diversification amid S&P 500 concentration concerns.
Nomura Holdings (NMR) trades at $9.59, up 0.63% with a bearish technical signal despite recent earnings beats. The company shows strong fundamentals with revenue growth from $1.66T to $1.98T projected for 2026, net income margin of 20.4%, and attractive valuation ratios including P/E of 11.33. Recent news highlights technical pattern recognition and inclusion on Zacks Strong Buy lists, though cash flow trends show operational challenges.
NMR presents a mixed outlook with undervalued fundamentals against bearish technicals. Investment opportunity lies in discounted valuation and earnings momentum, but risks include negative operating cash flows, rising debt-to-asset ratios, and inconsistent earnings performance. Analyst consensus leans cautious with 67% hold ratings despite recent positive coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares Core MSCI EAFE ETF
IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
